Abstract

Correction to: Prostate Cancer and Prostatic Diseases, published online 14 September 2022 The article Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases, written by, Martin W. Schoen, Kenneth R. Carson, Seth A. Eisen, Charles L. Bennett, Suhong Luo, Melissa A. Reimers, Eric M. Knoche1, Alison L. Whitmer, Yan Yan, Bettina F. Drake and Kristen M. Sanfilippo was originally published electronically on the publisher’s internet portal on 14 September 2022 without open access.

Original languageEnglish
Pages (from-to)811
Number of pages1
JournalProstate Cancer and Prostatic Diseases
Volume26
Issue number4
DOIs
StatePublished - Dec 2023

Fingerprint

Dive into the research topics of 'Correction to: Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases (Prostate Cancer and Prostatic Diseases, (2023), 26, 4, (743-750), 10.1038/s41391-022-00588-5)'. Together they form a unique fingerprint.

Cite this